{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T17:32:30Z","timestamp":1787679150172,"version":"build-2784847793"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T00:00:00Z","timestamp":1613692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004008","name":"Istituto Superiore di Sanit\u00e0","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004008","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Huntington\u2019s disease (HD) is a life-threatening neurodegenerative disorder. Altered levels and functions of the purinergic ionotropic P2X7 receptors (P2X7Rs) have been found in animal and cellular models of HD, suggesting their possible role in the pathogenesis of the disease; accordingly, the therapeutic potential of P2X7R antagonists in HD has been proposed. Here we further investigated the effects of P2X7R ligands in <jats:italic>in vitro<\/jats:italic> and <jats:italic>ex vivo<\/jats:italic> HD experimental models. In ST14A\/Q120 rat striatal cells, we found a reduction of P2X7R expression; however, the P2X7R agonist 2\u2032(3\u2032)-O-(4-benzoylbenzoyl)adenosine-5\u2032-triphosphate (BzATP) induced cellular death, and this effect was fully reversed by the antagonist periodate-oxidized adenosine 5\u2032-triphosphate (OxATP). Moreover, in corticostriatal slices from symptomatic R6\/2 mice, BzATP reduced the synaptic transmission to a larger extent than in wild-type (WT) mice. Such an effect was accompanied by a concomitant increase of the paired-pulse ratio, suggesting a presynaptic inhibitory action. This was confirmed to be the case, since while the effects of BzATP were unaffected by the P2X7R antagonist OxATP, they were blocked by the adenosine A<jats:sub>1<\/jats:sub> receptor (A<jats:sub>1<\/jats:sub>R) antagonist 8-cyclopentyl-1,3-dipropylxanthine (DPCPX), suggesting possible BzATP hydrolysis to 2\u2032(3\u2032)-O-(4-benzoylbenzoyl)adenosine (Bz-adenosine) and consequent activation of A<jats:sub>1<\/jats:sub>Rs as a mechanism. Taken together, these data point out that 1) P2X7R expression and activity are confirmed to be altered in the presence of HD mutation; 2) in some experimental settings, such an abnormal functioning can be ascribed to presynaptic A<jats:sub>1<\/jats:sub>Rs activation.<\/jats:p>","DOI":"10.3389\/fphar.2020.633861","type":"journal-article","created":{"date-parts":[[2021,2,21]],"date-time":"2021-02-21T00:51:55Z","timestamp":1613868715000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["P2X7 Receptor Agonist 2\u2032(3\u2032)-O-(4-Benzoylbenzoyl)ATP Differently Modulates Cell Viability and Corticostriatal Synaptic Transmission in Experimental Models of Huntington\u2019s Disease"],"prefix":"10.3389","volume":"11","author":[{"given":"Alberto","family":"Martire","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Pepponi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Liguori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Volont\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Popoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,2,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1124\/pr.58.3.3","article-title":"International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy","volume":"58","author":"Abbracchio","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"B2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0165-0270(01)00374-0","article-title":"The LTP Program: a data acquisition program for on-line analysis of long-term potentiation and other synaptic events","volume":"108","author":"Anderson","year":"2001","journal-title":"J. Neurosci. Methods"},{"key":"B3","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/sj.bjp.0705470","article-title":"Oxidized ATP (oATP) attenuates proinflammatory signaling via P2 receptor-independent mechanisms","volume":"140","author":"Beigi","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1097\/00004647-199710000-00014","article-title":"A possible mechanism for the aglycemia-induced depression of glutamatergic excitation in the striatum","volume":"17","author":"Calabresi","year":"1997","journal-title":"J. Cerebr. Blood Flow Metabol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/(SICI)1097-4547(19980715)53:2<223::AID-JNR11>3.0.CO;2-7","article-title":"Generation and characterization of embryonic striatal conditionally immortalized ST14A cells","volume":"53","author":"Cattaneo","year":"1998","journal-title":"J. Neurosci. Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/jnr.1244","article-title":"NMDA receptor function in mouse models of Huntington disease","volume":"66","author":"Cepeda","year":"2001","journal-title":"J. Neurosci. Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1098\/rstb.1999.0449","article-title":"Altered neurotransmitter receptor expression in transgenic mouse models of Huntington\u2019s disease","volume":"354","author":"Cha","year":"1999","journal-title":"Philos. Trans. R. Soc. London.Series B Biol. Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/j.1471-4159.2005.03029.x.","article-title":"CGS21680 attenuates symptoms of Huntington\u2019s disease in a transgenic mouse model","volume":"93","author":"Chou","year":"2005","journal-title":"J. Neurochem."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1523\/jneurosci.18-06-01987.1998","article-title":"Inhibition by ATP of hippocampal synaptic transmission requires localized extracellular catabolism by ecto-nucleotidases into adenosine and channeling to adenosine A1 receptors","volume":"18","author":"Cunha","year":"1998","journal-title":"J. Neurosci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1096\/fj.08-122275","article-title":"Altered P2X7-receptor level and function in mouse models of Huntington\u2019s disease and therapeutic efficacy of antagonist administration","volume":"23","author":"Diaz-Hernandez","year":"2009","journal-title":"Faseb. J."},{"key":"B12","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/s0074-7742(08)60556-5","article-title":"The physiological role of adenosine in the central nervous system","volume":"27","author":"Dunwiddie","year":"1985","journal-title":"Int. Rev. Neurobiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"7673","DOI":"10.1523\/jneurosci.17-20-07673.1997","article-title":"Adenine nucleotides undergo rapid, quantitative conversion to adenosine in the extracellular space in rat hippocampus","volume":"17","author":"Dunwiddie","year":"1997","journal-title":"J. Neurosci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1006\/exnr.2000.7551","article-title":"ST14A cells have properties of a medium-size spiny neuron","volume":"167","author":"Ehrlich","year":"2001","journal-title":"Exp. Neurol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.nbd.2014.08.013","article-title":"Expression, pharmacology and functional activity of adenosine A1 receptors in genetic models of Huntington\u2019s disease","volume":"71","author":"Ferrante","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3389\/fnmol.2020.00094","article-title":"The role of P2X7 receptor in Alzheimer\u2019s disease","volume":"13","author":"Francistiov\u00e1","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"6325","DOI":"10.1523\/JNEUROSCI.17-16-06325.1997","article-title":"P2 receptor excitation of rodent hypoglossal motoneuron activity in vitro and in vivo: a molecular physiological analysis","volume":"17","author":"Funk","year":"1997","journal-title":"J. Neurosci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.nbd.2004.05.008","article-title":"Adenosine and glutamate extracellular concentrations and mitogen-activated protein kinases in the striatum of Huntington transgenic mice. Selective antagonism of adenosine A2A receptors reduces transmitter outflow","volume":"17","author":"Gianfriddo","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/s0306-4522(00)00008-7","article-title":"The pattern of neurodegeneration in Huntington\u2019s disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington\u2019s disease","volume":"97","author":"Glass","year":"2000","journal-title":"Neuroscience"},{"key":"B20","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1136\/jmg.29.4.239","article-title":"Age at onset and life table risks in genetic counselling for Huntington\u2019s disease","volume":"29","author":"Harper","year":"1992","journal-title":"J. Med. Genet."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1124\/jpet.106.111559","article-title":"A-740003 [N-(1-{[(cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat","volume":"319","author":"Honore","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B22","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.neuroscience.2004.06.014","article-title":"P2X 7-like receptor subunits enhance excitatory synaptic transmission at central synapses by presynaptic mechanisms","volume":"128","author":"Ireland","year":"2004","journal-title":"Neuroscience"},{"key":"B23","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.neuropharm.2008.06.067","article-title":"ATP-gated P2X cation-channels","volume":"56","author":"Jarvis","year":"2009","journal-title":"Neuropharmacology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"37350","DOI":"10.1074\/jbc.M707915200","article-title":"Extracellular ATP mediates necrotic cell swelling in SN4741 dopaminergic neurons through P2X7 receptors","volume":"282","author":"Jun","year":"2007","journal-title":"J. Biol. Chem."},{"key":"B25","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1007\/s002100000315","article-title":"Adenosine receptors and their ligands","volume":"362","author":"Klotz","year":"2000","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"7128","DOI":"10.1523\/JNEUROSCI.2093-04.2004","article-title":"Ecto-nucleotidases and nucleoside transporters mediate activation of adenosine receptors on hippocampal mossy fibers by P2X7 receptor agonist 2\u2032-3\u2032-O-(4-benzoylbenzoyl)-ATP","volume":"24","author":"Kukley","year":"2004","journal-title":"J. Neurosci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1002\/(SICI)1097-4547(19991115)58:4<515::AID-JNR5>3.0.CO;2-F","article-title":"Enhanced sensitivity to N-methyl-D-aspartate receptor activation in transgenic and knockin mouse models of Huntington\u2019s disease","volume":"58","author":"Levine","year":"1999","journal-title":"J. Neurosci. Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1038\/sj.bjp.0704624","article-title":"Stimulation of Ca(2+) influx through ATP receptors on rat brain synaptosomes: identification of functional P2X(7) receptor subtypes","volume":"135","author":"Lundy","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/s0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"B30","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.neulet.2007.02.034","article-title":"Opposite effects of the A2A receptor agonist CGS21680 in the striatum of Huntington\u2019s disease versus wild-type mice","volume":"417","author":"Martire","year":"2007","journal-title":"Neurosci. Lett."},{"key":"B31","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/jnc.12177","article-title":"BDNF prevents NMDA-induced toxicity in models of Huntington\u2019s disease: the effects are genotype specific and adenosine A2A receptor is involved","volume":"125","author":"Martire","year":"2013","journal-title":"J. Neurochem."},{"key":"B32","doi-asserted-by":"publisher","first-page":"7063","DOI":"10.1523\/JNEUROSCI.3104-16.2017","article-title":"Neuronal P2X7 receptor: involvement in neuronal physiology and pathology","volume":"37","author":"Miras-Portugal","year":"2017","journal-title":"J. Neurosci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3389\/fphys.2020.00473","article-title":"Peripheral inflammatory hyperalgesia depends on P2X7 receptors in satellite glial cells","volume":"11","author":"Neves","year":"2020","journal-title":"Front. Physiol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1111\/j.1471-4159.2012.07868.x","article-title":"Mitochondrial dysfunction is involved in P2X7 receptor-mediated neuronal cell death","volume":"122","author":"Nishida","year":"2012","journal-title":"J. Neurochem."},{"key":"B35","doi-asserted-by":"publisher","first-page":"567430","DOI":"10.3389\/fnmol.2020.567430","article-title":"P2X7 receptor upregulation in Huntington\u2019s disease brains","volume":"13","author":"Oll\u00e0","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"B36","first-page":"413","article-title":"Receptors for purines and pyrimidines","volume":"50","author":"Ralevic","year":"1998","journal-title":"Pharmacol. Rev."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1098\/rstb.1999.0456","article-title":"Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington\u2019s disease","volume":"354","author":"Reddy","year":"1999","journal-title":"Philos. Trans. R. Soc. London.Series B Biol. Sci."},{"key":"B38","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1146\/annurev.pharmtox.38.1.257","article-title":"The mammalian carboxylesterases: from molecules to functions","volume":"38","author":"Satoh","year":"1998","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"5325","DOI":"10.1523\/JNEUROSCI.14-09-05325.1994","article-title":"Changes in paired-pulse facilitation suggest presynaptic involvement in long-term potentiation","volume":"14","author":"Schulz","year":"1994","journal-title":"J. Neurosci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1046\/j.1471-4159.2002.00920.x","article-title":"Involvement of P2X7 receptors in the regulation of neurotransmitter release in the rat hippocampus","volume":"81","author":"Sperl\u00e1gh","year":"2002","journal-title":"J. Neurochem."},{"key":"B41","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.nbd.2006.01.014","article-title":"Early and transient alteration of adenosine A2A receptor signaling in a mouse model of Huntington disease","volume":"23","author":"Tarditi","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1111\/j.1471-4159.2009.06282.x","article-title":"Adenosine A2A receptors enable the synaptic effects of cannabinoid CB1 receptors in the rodent striatum","volume":"110","author":"Tebano","year":"2009","journal-title":"J. Neurochem."},{"key":"B43","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.arr.2015.10.001","article-title":"Emerging role of P2X7 receptors in CNS health and disease","volume":"24","author":"Tewari","year":"2015","journal-title":"Ageing Res. Rev."},{"key":"B44","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-e","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes","volume":"72","year":"1993","journal-title":"Cell"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1096\/fj.00-0730fje","article-title":"Aberrant amplification of A(2A) receptor signaling in striatal cells expressing mutant huntingtin","volume":"15","author":"Varani","year":"2001","journal-title":"Faseb. J."},{"key":"B46","doi-asserted-by":"publisher","first-page":"705","DOI":"10.2174\/187152712803581137","article-title":"P2X7 receptors: channels, pores and more","volume":"11","author":"Volont\u00e9","year":"2012","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"B47","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington\u2019s disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1002\/ana.21313","article-title":"Adenosine A2A receptor antagonists exert motor and neuroprotective effects by distinct cellular mechanisms","volume":"63","author":"Yu","year":"2008","journal-title":"Ann. Neurol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/s0896-6273(02)00615-30","article-title":"Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington\u2019s disease","volume":"33","author":"Zeron","year":"2002","journal-title":"Neuron"},{"key":"B50","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/0301-0082(96)00026-3","article-title":"Biochemistry, localization and functional roles of ecto-nucleotidases in the nervous system","volume":"49","author":"Zimmermann","year":"1996","journal-title":"Prog. Neurobiol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2020.633861\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,21]],"date-time":"2021-02-21T00:51:57Z","timestamp":1613868717000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2020.633861\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,19]]},"references-count":50,"alternative-id":["10.3389\/fphar.2020.633861"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2020.633861","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,19]]},"article-number":"633861"}}